Discovery of a Peripherally Directed CB<sub>1</sub> Receptor Antagonist That Restores Insulin Signaling in Adipocytes. [PDF]
Azuaje J +19 more
europepmc +1 more source
Sterol carrier protein 2 loss reduces anxiety and enhances fear extinction. [PDF]
Liedhegner ES +7 more
europepmc +1 more source
Involvement of CB1 cannabinoid receptors in methamphetamine-related decision-making and social behavior deficits. [PDF]
Mousavi T +7 more
europepmc +1 more source
Endocannabinoid system and skeletal muscle health: Insights from cannabidiol. [PDF]
Deglos A +3 more
europepmc +1 more source
Rimonabant (acomplia®), obésité et diabiète de type 2
Le rimonabant (Acomplia®) est une molécule au mécanisme d'action original, antagoniste du récepteur CB1 du système endocannabinoïde qui joue un rôle majeur dans la régulation de l'équilibre énergétique du corps.
BESSIERES, Hélène +1 more
core
Discrete Choice Experiment (DCE) as a Tool to Elicit Patient Preferences in a Complex Benefit-Risk Evaluation: A Case Study. [PDF]
E JY +5 more
europepmc +1 more source
Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies. [PDF]
Costa GPA +7 more
europepmc +1 more source
The invention relates to 3-methylbutan-1-ol solvate of rimonabant, preparation method thereof and therapeutic use of ...
Coquerel, Gérard, Fours, Baptiste
core
Acetaminophen alters endogenous lipid signaling and attenuates pathological pain through a mechanism requiring diacylglycerol lipase, monoacylglycerol lipase and cannabinoid CB1 receptors in mice. [PDF]
Jesus CHA +13 more
europepmc +1 more source
Cannabinoid 1 receptor occupancy and neurovascular responses induced by agonist, antagonist/inverse-agonist and potential modulator in non-human primate brains: PET/fMRI study. [PDF]
Yoo CH +5 more
europepmc +1 more source

